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Abstract
Inhibin and activin are essential dimeric glycoproteins belonging to the transforming growth factor-beta (TGFb) superfamily.
Inhibin is a heterodimer of a- and b-subunits, whereas activin is a homodimer of b-subunits. Production of inhibin is
regulated during the reproductive cycle and requires the processing of pro-ligands to produce mature hormone. Furin is a
subtilisin-like proprotein convertase (proconvertase) that activates precursor proteins by cleavage at basic sites during their
transit through the secretory pathway and/or at the cell surface. We hypothesized that furin-like proconvertases are central
regulators of inhibin a- and b-subunit processing within the ovary. We analyzed the expression of the proconvertases furin,
PCSK5, PCSK6, and PCSK7 in the developing mouse ovary by real-time quantitative RT-PCR. The data showed that
proconvertase enzymes are temporally expressed in ovarian cells. With the transition from two-layer secondary to pre-antral
follicle, only PCSK5 mRNA was significantly elevated. Activin A selectively enhanced expression of PCSK5 mRNA and
decreased expression of furin and PCSK6 in cultured two-layer secondary follicles. Inhibition of proconvertase enzyme
activity by dec-RVKR-chloromethylketone (CMK), a highly specific and potent competitive inhibitor of subtilisin-like
proconvertases, significantly impeded both inhibin a- and b-subunit maturation in murine granulosa cells. Overexpression
of PC5/6 in furin-deficient cells led to increased inhibin a- and bB-subunit maturation. Our data support the role of
proconvertase PCSK5 in the processing of ovarian inhibin subunits during folliculogenesis and suggest that this enzyme
may be an important regulator of inhibin and activin bioavailability.
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Introduction
Growth and development of primordial follicles to ovulatory
status is associated with marked proliferation, recruitment and
differentiation of somatic cells and changes in oocyte size and
morphology that reflect both nuclear and cytoplasmic maturation.
Inhibins, activins and follistatins were first identified in ovarian
follicular fluid by their ability to modulate the secretion of FSH
from pituitary gonadotrophs. Inhibins and follistatin suppress FSH
secretion, whereas activins enhance FSH secretion. Although a
long-loop negative feedback role for ovarian inhibins in the
regulation of FSH secretion is now well established in both sexes
[1,2,3], it is unlikely that activins of ovarian origin exert endocrine
effects on the pituitary. Rather, activins are produced by, and
subserve local regulatory roles in a diverse range of tissues,
including the anterior pituitary. Recently, we identified a positive
short feedback loop in pituitary gonadotrope cells that augments
the secretion of bioactive mature activin B and inhibin B necessary
for local FSH regulation [4]. The granulosa cell of the ovary
produces inhibin A and inhibin B; however, the secretion patterns
for these ligands are distinct, suggesting an underlying control over
biosynthesis and release. Preliminary studies in our lab described
differential secretion patterns of inhibin A and inhibin B during
the rat reproductive cycle, differential compartmentalization of
inhibin subunit protein in granulosa cells of developing follicles,
and the differential regulation of biosynthetic processing of inhibin
isoforms [5]. Like TGFb and many other growth factors, the
inhibin a-, bA- and bB-subunits are cleaved by proconvertases to
generate mature active peptides. Proconvertases are a family of
serine proteases structurally related to the endoproteases bacterial
subtilisin and yeast kexin, and cleave precursors of polypeptides at
the carboxylterminal end of single or paired basic residues. To
date, seven mammalian proconvertases have been identified
[6,7,8,9,10,11,12]. Of these, furin (PCSK3), PC5/6 (PCSK5),
PACE4 (PCSK6) and PC7 (PCSK7) exhibit widespread tissue
distribution, whereas PC1 (PCSK1) and PC2 (PCSK2) are
expressed only in endocrine and neuroendocrine tissues and cells
[12,13,14]. PC5/6 is encoded as two splice variants: PC5/6A and
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17348PC5/6B [7,8,15]. PC5/6A is the major isoform in most tissues,
whereas PC5/6B is predominately expressed in the intestine and
kidney [16].
An early step in the biosynthesis of inhibin involves the
attachment of N-linked oligosaccharides to the inhibin subunits.
We have demonstrated that specific oligosaccharide attachment
to the a- and bA-subunits direct the differential assembly and
secretion of inhibin A and activin A dimers [17]. We further
showed that the inhibin a-a n dbB-subunits are targets of furin
processing and that activin A positively regulates furin through
a Smad2/3-dependent pathway in pituitary gonadotrope cells
[4]. Here, we extend these studies by characterizing the mRNA
expression of the a-, bA-a n dbB-subunits and the proconver-
tases (furin, PCSK5, PCSK6, and PCSK7) during early mouse
ovarian development and folliculogenesis. We found that inhibin
bioactivity and maturation in the ovary involves the activation
of different proconvertases, and we provide novel evidence that
the inhibin a-a n dbB-subunits are substrates of the proconver-
tase PC5/6 and that activin A is a likely regulator of this
enzyme in mouse granulosa cells. These studies provide insight
into the control of inhibin and activin synthesis in mouse
ovarian granulosa cells and contribute to a more complete
understanding of the processes involved in normal folliculogen-
esis, as well as the potential mechanisms that may underlie
infertility secondary to inappropriate ovarian hormone produc-
tion and secretion.
Materials and Methods
Recombinant ligands, plasmids and chemical reagents
Recombinant human activin A was purified as reported
previously [18]. Recombinant activin B (R&D Systems, Minne-
apolis, MN) was reconstituted in 0.1% BSA in phosphate buffered
saline (PBS). The human inhibin a-subunit and bB-subunit cDNAs
were provided by Genentech (South San Francisco, CA). Human
furin, PC5/6A, PC5/6B and PC7 expression plasmids were a kind
gift from Dr. J.W. Creemers (Katholieke Universiteit Leuven,
Belgium). The Pace4 expression plasmid was a kind gift from Dr.
A. Tsuji (University of Tokushima, Japan). The furin inhibitor,
dec-RVKR-chloromethylketone (CMK) was purchased from
Alexis Biochemicals (San Diego, CA). Site-directed mutagenesis
of the a-subunit cleavage site was performed by PCR as described
previously [17]. Primers used for mutagenesis of the inhibin a-
subunit cleavage site are: RARRRRARA (forward: ccacccagtg-
gaggggagaga gcccgagcctcaactcccctg; reverse: caggggagttgaggctcgggc-
tctctcccctccactgggtgg) and RARRRRAAA (forward: ccacccagtg-
gaggggagagagccgccgcctcaactcccctg; reverse: caggggagttgaggcggcggctct-
ctcccctccact gggtgg). Mutants were confirmed by DNA sequence
analysis at the Northwestern University Biotech Core Facility.
Animals
Ovaries were removed from prepubertal 2-, 6-, 10- and 19-day-
old female F1 hybrids (C57BL/6XCBA). Primary cultures of
mouse granulosa cells were isolated from adult mice by needle
puncture as previously described [19]. Breeding pairs and
prepubertal mice were housed in a temperature-controlled and
light-controlled environment (14L:10D), and were provided with
food and water ad libidum. Animals were treated in accordance
with the National Institutes of Health Guide for the Care and Use
of Laboratory Animals. The protocols used were approved by the
IACUC (ACUC protocol 2003-0026) at Northwestern University.
Unless otherwise noted, all media formulations were purchased
from Invitrogen (Carlsbad, CA).
Cell lines
The GRMO2 mouse granulosa cell line was provided by N.V.
Innogenetics (Ghent, Belgium) [20]. GRMO2 cells were grown in
HDTIS (1:1 mixture of DMEM and Ham’s F-12 medium, 10 mg/
ml insulin, 5 nM sodium selenite and 5 mg/ml transferrin
supplemented with 2% fetal bovine serum and sodium pyruvate
[100 mg/liter]) in a humidified incubator at 37uC and 5% CO2 as
described previously [20]. A furin-deficient human colon adeno-
carcinoma cell line (LoVo) was obtained from the ATCC
(Rockville, MD). LoVo and human embryonic kidney (HEK
293) cells were grown and maintained in DMEM supplemented
with 10% fetal calf serum and 1% antibiotic as described [4].
Follicle isolation, encapsulation and culture
Primary, two-layer secondary, multi-layer secondary and antral
follicles were mechanically isolated and collected from day 8, 12,
16, 21–22 mice as described below. Follicles were classified as
follows: primordial follicles (,50 mm); primary follicles (50–
100 mm; harvested only from day 8 mouse ovaries); two-layer
secondary follicles (100–130 mm; harvested only from day 12
mouse ovaries); multilayer secondary follicles (150–180 mm;
harvested only from day 16 mouse ovaries); antral follicles (280–
340 mm; harvested only from days 21–22 mouse ovaries) and
preovulatory follicles (.500 mm; harvested only from .day 22
ovaries) (20–22). Follicles were flash frozen in liquid nitrogen prior
to RNA isolation. For RNA isolation, follicles were pooled by size:
110 primary follicles, 45 secondary follicles; 25 multilayer
secondary follicles; 15 early antral follicles and 12 pre-ovulatory
follicles. RNA was purified using the Absolutely RNA Microprep
Kit (Stratagene, Cedar Creek, TX) according to the manufactur-
er’s protocol. RNA quality was verified using the RNA 6000 Nano
Chip Assay (Agilent Technologies, Santa Clara, CA).
For follicle culture experiments, two-layer secondary follicles
(100–130 mm diameter) were mechanically isolated from the
ovaries of 12-day-old females and encapsulated in alginate as
previously described [21,22,23]. Throughout isolation, encapsula-
tion and culture, the follicles were maintained at 37uC and pH 7.
After a series of experiments to determine effective activin A and
activin B concentrations on inhibin a- and bB-subunits in
immortalized cell lines (data not shown; Antenos et al., 2008),
follicles were cultured for a 4-day period in culture media
consisting of aMEM, 3 mg/ml BSA, 10 mIU/ml rFSH, 5 mg/ml
insulin, 5 mg/ml transferrin and 5 ng/ml selenium supplemented
with 50 ng/ml of activin A or activin B. The concentration of
activin used is similar to the doses of activin known to promote
human and ovine follicle development [24,25]. Each encapsulated
follicle occupied a single well of a 96-well plate. After 2 days of
culture, the media in each well was changed and fresh culture
media supplemented with vehicle, activin A or activin B was
added. Follicle diameter and overall health was assessed using a
Leica DM IRB microscope with transmitted light and phase
objectives (Leica, Bannockburn, IL). At the end of the 4-day
culture, follicles were removed from alginate beads using alginate
lysase (10 IU/ml). Follicles from each condition were collected,
pooled (16–20/group), and subjected to real-time RT-PCR
analysis as described below.
Quantitative real-time RT-PCR
RNA was reverse transcribed into first strand cDNA using the
Advantage Reverse PCR kit (Clontech, Mountain View, CA).
Real-time RT-PCR was programmed according to the manufac-
turer’s instructions. From the original RT reaction, 1.5 ml was
subjected to PCR amplification in a 25 ml volume with Taqman
Universal PCR Master Mix (Applied Biosystems, Foster City, CA)
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for 10 min, then 40 cycles of 95uC for 15 s, and 60uC for 1 min.
Primer and probe sets were FAM (6-carboxy-fluorescein) labeled
and acquired from Applied Biosystems Assays on demand and
designed to span intron/exon borders for inhibin bA (Mm0043
4338), bB (Mm01286587), a (Mm00439683), furin (Mm0044
0646), PCSK5 (Mm01206139), PCSK6 (Mm01319134) and
PCSK7 (Mm00476614). Data were normalized with VIC-labeled
GAPDH as the internal control (DCt). The threshold levels of
GAPDH were not altered by any treatments. Standard error from
the mean from replicates are represented as 2‘2DDCt as described
[26].
Immunoblot analysis
Ovaries were homogenized in lysis buffer supplemented with
Complete Protease Inhibitor Tablets (Roche, Madison, WI) for
immunoblotting procedures as described [17]. Goat anti-rabbit
horseradish peroxidase-conjugated secondary antibody was pur-
chased from Zymed Laboratories. Immunoblot results were
visualized using an ECL detection reagent (Amersham Bioscienc-
es, Inc., Buckinghamshire, England) and exposed at varying time
points onto an X-ray film (Kodak, Rochester, New York, USA).
Proconvertase inhibition
The furin inhibitor, dec-RVKR-CMK, was added to cultures of
GRM02 cells for 48 h. Media was collected, trichloroacetic acid
(TCA) precipitated and subjected to immunoblot analysis under
reducing conditions.
Transfection
To assess processing of the inhibin subunits in HEK293 and
LoVo cells, cells were plated in a 24-well plate 1 day prior to
transfection at a confluency of ,80%. Cells were transfected with
empty vector, the wild type or cleavage site mutant inhibin a-
subunit expression plasmids or the proconvertase expression
plasmids as recommended by manufacturer and total DNA
transfected did not exceed 0.8 mg/well. After 18 h, media was
collected, (TCA) precipitated and analyzed by immunoblotting
procedures under reducing conditions.
Statistics: Values are reported as means 6 SEM and were
analyzed using Prism (Version 4.0a) (GraphPad Software, Inc.,
San Diego, CA). Analysis of variance (ANOVA), followed by
Tukey’s or Bonferonni post-tests, was used to evaluate differences
between treatments. Statistical significance was reported if
p,0.05.
Results
Expression of inhibin subunit mRNA transcripts and
protein in mouse ovaries
Numerous experiments to date have demonstrated that the
inhibin a-, bA- and bB-subunits are produced in granulosa cells of
the ovary and have very limited expression in other ovarian cells,
such as the epithelial, stromal or theca cells. We were interested in
determining the expression of these subunits and the activation of
these proteins as follicles grow. We first wanted to determine the
expression profiles of the inhibin subunits in day 2, 6, 10 and 19
whole mouse ovaries by real-time RT-PCR. Ovaries from mice of
specific ages (d2, d6, d10 and d19) were pooled and mRNA
transcript levels of the inhibin a-, bA- and bB-subunits were
assessed. A significant 3-fold change in the inhibin a-subunit
mRNA levels was observed between day 2 and day 6 (Figure 1A).
The mRNA levels for this subunit continued to increase to
approximately 7-fold at day 10, and at day 19. A 4-fold increase in
bA-subunit was observed at day 6 compared with day 2 ovaries
(Figure 1B), followed by a vast increase in bA-subunit levels by day
10 of ovary development. These levels decreased by day 19;
however, abundant levels of the inhibin bA-subunit remained. In
contrast to the bA-subunit, the levels of the bB-subunit transcript
varied little between day 2, 6 and 10 ovaries (Figure 1C), but by
day 19, the levels of the bB-subunit mRNA had increased
approximately 3-fold.
We next examined the levels of the inhibin subunits in ovarian
protein lysates (40 mg/lane) from day 6, 10 and 19 ovaries by
immunoblot. The relative amounts of each subunits protein
increased with ovarian development, and as more protein was
observed, a concomitant increase in the relative amounts of
processed or cleaved mature subunits accumulated (Figures 1D–F).
Day 19 ovarian lysates contained the highest levels of inhibin
subunit proteins and also contained the most processed mature
forms in the ovarian lysates. The relative increase in subunit
expression closely matched those observed at the mRNA level and
confirmed that the inhibin subunit genes and proteins are
expressed and dynamically up-regulated during ovarian follicle
development. The dynamic regulation of the inhibin subunits led
us to investigate the expression and regulation of proconvertases
thought to be necessary for maturation of inhibin and activin
peptide hormones in ovarian granulosa cells.
Furin, PCSK5, PCKS6 and PCSK7 mRNA expression in the
mouse ovary
Our previous study demonstrated that activin treatment of
pituitary gonadotrope (LbT2) cells positively regulated the
production of furin mRNA through a pathway that involved the
TGFb receptor-activated transcription factors Smad2 and Smad3
[4]. With an increase of inhibin a- and b-subunit mRNA in
growing follicles, we hypothesized an accompanying increase in
furin mRNA levels over time. To test this, RNA was collected
from ovaries of day 2, 6, 10 and 19 mice for quantitative real-time
RT-PCR analysis. In contrast to our findings in the mouse
pituitary, the relative levels of furin mRNA significantly decreased
in the developing ovary when compared with day 2 ovaries
(Figure 2A). The data suggests that the relative level of furin
mRNA is inversely related to the level of the inhibin subunits in
developing ovaries. We thus predicted that other enzymes
belonging to the proconvertase family might be involved in
inhibin subunit maturation. To determine the mRNA levels of
PCSK5, PCSK6 and PCSK7 in whole ovaries, RNA was isolated
from ovaries of d2, d6, d10, and d19 mice for quantitative real-
time RT-PCR analysis. Of all enzymes examined, only PCSK5
mRNA was significantly elevated, by approximately 4-fold, when
compared with day 2 ovaries (Figure 2B). In contrast, the relative
amounts of PCSK6 and PCSK7 decreased when compared with
day 2 ovaries, analogous to the mRNA expression profile of furin.
Inhibin a-, bA- and bB-subunit mRNA transcript levels in
isolated follicles
Our goal was to determine which proconvertase enzymes cleave
the inhibin subunits during ovary development and folliculogen-
esis. To identify follicle-specific inhibin subunit and proconvertase
expression, we mechanically isolated follicles of various sizes from
mouse ovaries. Follicles were isolated as previously described
[21,22] and RNA was collected from each group as described
above in the Methods. Figure 3 graphically represents the mRNA
expression of the inhibin a-, bA- and bB-subunits from each group
of follicles. Compared with 50–100 micron follicles, the expression
of the inhibin a-subunit increased approximately 1.7-fold in 150–
Processing of Inhibin Subunits
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mRNA levels (2.8 fold) was measured in 280–340 micron follicles.
bA-subunit mRNA transcripts also increased significantly as
follicles grew. The highest level of expression was observed in
follicles greater than 500 microns (.500 fold) (Figure 3B). bB-
subunit mRNA transcripts were also significantly higher in
.500 micron follicles, with an approximate 4-fold increase in
transcript levels compared to the smallest follicle group (Figure 3C).
Thus, all three subunits are expressed and detectable in the
appropriate follicle classes.
Proconvertase mRNA transcript levels in isolated follicles
We next measured the mRNA levels of the proconvertases in
each of the follicle classes (Figure 4). For each proconvertase
examined, only the mRNA levels of PCSK5 increased significantly
in 150–180 micron follicles (Figure 4B). This was consistent with
the elevated PCSK5 mRNA levels that were observed in whole
ovaries (Figure 2B). Also consistent with the data presented for the
whole ovaries (Figure 2A), furin mRNA levels decreased
significantly with follicle development. The trends observed for
PCSK6 and PCSK7 expression were similar to that of furin, with a
decrease in transcript levels as follicle size increased (Figures 2C,
4C and 4D). A concomitant increase in both inhibin a-subunit
mRNA transcripts and PCSK5 mRNA transcripts in multilayer
secondary follicles (150–180 microns) suggested that PC5/6 may
be the proconvertase responsible for cleavage and activation of
inhibin in the ovary.
Activins regulate inhibin subunit and PCSK mRNA levels
in secondary follicles
Since early follicle development is thought to be activin-
dependent [27]; [28,29], we questioned whether activins could
effect the expression of inhibin subunits and PCSKs during follicle
development. Two-layer secondary follicles (100–130 microns)
were mechanically isolated from day 12 mouse ovaries and
cultured for 4 days in the presence or absence of 50 ng/ml of
either activin A or activin B [24,25]. Two-layer secondary follicles
were chosen in these experiments since no significant differences
between any of the PCSK mRNA transcripts were observed at this
stage (Figure 4). After this culture period, RNA was isolated from
each group of follicles and the transcript levels of the inhibin
subunits were assessed. Both the inhibin a-subunit and bA-subunit
Figure 1. Expression of inhibin a-, bA- and bB-subunits in the postnatal mouse ovary. Basal expression levels of inhibin a- (A), bA- (B) and
bB- (C) subunits in developing mouse ovaries were determined by real-time RT-PCR. The mRNA levels of the subunits are shown as a ratio over the
day 2 ovary mRNA levels (control). Detection of the inhibin a- (D), bA- (E) and bB- (F) subunit protein in ovarian lysates from day 6, day 10 and day 19
ovaries. Ovarian lysates were collected, separated under reducing conditions; each subunit was detected by immunoblotting with the corresponding
rabbit polyclonal antibody. Forty mg of protein was loaded per lane. Equal loading of lysates was confirmed with an anti-actin antibody.
doi:10.1371/journal.pone.0017348.g001
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activin B (Figure 5A). A 1.5-fold increase was observed in the
inhibin a-subunit expression with activin treatment. A 3-fold
increase was observed for the bA-subunit transcript. The bB-
subunit mRNA levels did not change in response to hormone
treatment. Follicle diameters were measured for each group of
treated follicles (Figure 5B). During this 4-day culture period,
activin A-treated follicles grew significantly compared with
controls [24,25].
The mRNA transcript levels for each PCSK were then assessed
in the activin-treated follicles. Compared with untreated follicles,
furin and PCSK6 mRNA levels decreased significantly with
activin A treatment, whereas PCSK5 mRNA levels increased
Figure 2. Expression of PCSKs in the postnatal mouse ovary. (A)
Basal expression levels of furin mRNA in developing mouse ovaries was
determined by real-time RT-PCR. The furin mRNA levels are shown as a
ratio over the day 2 ovary mRNA levels (control). The bars labeled with
different letters indicate statistically significant differences, as deter-
mined by Tukey’s multiple comparison test (p,0.05). (B) Basal
expression levels of PCSK5, PCSK6 and PCSK7 mRNA in developing
mouse ovaries were determined by real-time RT-PCR and are shown as
a ratio over day 2 ovary mRNA levels (control). The bars labeled with
different letters indicate statistically significant differences, as deter-
mined by a two-way ANOVA followed by Bonferonni post-tests
(p,0.05).
doi:10.1371/journal.pone.0017348.g002
Figure 3. Expression levels of inhibin a-, bA- and bB-subunits in
mechanically isolated mouse follicles. Follicles were dissected and
grouped by size as described in the Materials and Methods. The mRNA
levels of the a- (A), bA- (B) and bB- (C) subunits were measured using
real-time RT-PCR and are shown as a ratio over the 50–100 micron
follicle group levels (control). The bars labeled with different letters
indicate statistically significant differences, as determined by Tukey’s
multiple comparison test (p,0.05).
doi:10.1371/journal.pone.0017348.g003
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unique to activin A treatment, since little change in PCSK
transcript levels was observed in follicles treated with activin B
(Figure 5C). We also assessed if estrogen affected PCSK5 levels.
No significant changes in PCSK5 expression occur following
estrogen treatment. This finding is supported by Okada et al,
(2005) which showed that the addition of estrogen to the culture
medium had no significant effect on the levels of PCSK5 mRNA
expression up to 6 days in culture. PCSK7 mRNA could not be
detected in follicles treated with activin A. Taken together, the
data provide evidence that activin A differentially affects
expression levels of PCSK mRNA transcripts in secondary follicles
cultured in vitro.
Relationship between PCSK gene expression and mature
inhibin a-and bB-subunit levels. The expression of the inhibin
subunits and PCSK enzymes were quantitatively assessed by real
time PCR of total RNA isolated from a primary culture of adult
mouse granulosa cells and immortalized mouse granulosa
(GRMO2) cells. In our characterization of these two cultures of
granulosa cells, real time PCR data showed that the basal mRNA
levels of the inhibin a-, bA-and bB-subunits were comparable in
both culture conditions (Figure 6A). A similar distribution pattern
of PCSK5, PCSK6 and PCSK7 mRNA transcripts were also
detected in both sources of granulosa cells (Figure 6B). We next
investigated the relationship between PCSKs and inhibin a-, bA-
and bB-subunit processing using GRMO2 cells. Cells were treated
with a potent and irreversible inhibitor of proconvertase enzymes,
decanoyl-RVKR-CMK (CMK), for 1 hour. Media was collected,
TCA-precipitated and subject to immunoblot analysis. As shown
in Figures 6C–6E, processing of each of the inhibin subunits was
inhibited by the presence of CMK. Accumulation of unprocessed
inhibin a-subunit in the media suggested that this inhibitor affects
cleavage but not secretion. The data imply a direct relationship
between proconvertase enzyme activity and the maturation of
inhibin a-, bA-and bB-subunits expressed in granulosa cells.
We further investigated the potential role of the C-terminal
proteolytic processing in the secretion of the inhibin a-subunit. We
previously reported the importance of this processing site in the
inhibin bB -subunit [4]. The predicted cleavage motif (RARR) at
amino acids 229–232 of the inhibin a-subunit (pro-aN-aC) was
verified by site-directed mutagenesis experiments. Two inhibin a-
subunit mutants (RARA and RAAA) were generated and
expressed in HEK293 cells. Compared with controls, cells
containing either cleavage site mutant inhibin a-subunit produced
unprocessed inhibin (confirming the earlier observation that
unprocessed inhibin can be secreted), but undetectable levels of
Figure 4. Expression levels of PCSKs in mechanically isolated mouse follicles. The mRNA levels of furin (A), PCSK5 (B), PCSK6 (C) and PCSK7
(D) subunits were measured using real-time RT-PCR and are shown as a ratio over the 50–100 micron follicle levels. The bars labeled with different
letters indicate statistically significant differences, as determined by Tukey’s multiple comparison test (p,0.05).
doi:10.1371/journal.pone.0017348.g004
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confirmed that cleavage of the inhibin a-subunit occurs at the
consensus cleavage motif and that mutagenesis of only the last
arginine (the RARA mutant) is sufficient to abolish C-terminal
proteolytic processing. The two arginine amino acids are not
equally important for processing as previously described [30] since
the secretion profile of this mutant (RAAA) did not differ
significantly from the RARA mutant.
To further validate that the inhibin a- and b-subunits are targets
of proconvertase processing, the furin-deficient (LoVo) cell line
was utilized. LoVo cells were transiently transfected with the
inhibin bB-o ra-subunit and expression vectors for PC5/6A,
PC5/6B, Pace 4 or PC7. After 48 h, the media was collected,
TCA precipitated and subject to immunoblotting procedures
under reducing conditions. Overexpression of PC5/6A or PC5/
6B resulted in the cleavage and secretion of pro-bB proteins, and
PC5/6A was more efficient than PC5/6B (Figure 7B). Overex-
pression of Pace4 or PC7 (data not shown) did not cleave pro-bB
protein. Consistent with our previous report, furin cleaved inhibin
pro-aN-aC (Figure 7C) [4]. Overexpression of either PC5/6A or
PC5/6B cleaved the inhibin precursor and more mature aC
protein was observed when compared with control. Very low
levels of aC were also evident with Pace4 and PC7 overexpression,
suggesting that these proconvertase enzymes are able to cleave the
inhibin a-subunit with different efficiencies. To our knowledge, the
data presented here provide the first evidence that the inhibin bB-
and a-subunits are targets of PC5/6 cleavage.
Discussion
Our findings represent an extension of previous work from our
group suggesting that proconvertases mediate processing of
inhibin subunits in the pituitary [4]. While we found previously
that furin cleaves the a- and bB-subunits in pituitary gonadotrope
cells, here, we observed a decrease in the expression of furin
mRNA transcripts during follicle development. This finding is
consistent with a previous report examining furin levels in the
ovary of the medaka, Oryzias latipes [31]. Ogiwara et al (2004)
Figure 5. mRNA transcript levels of inhibin subunits and PCSKs in activin-treated in vitro cultured mouse follicles. Secondary follicles
(100–130 microns) were mechanically isolated and cultured in alginate supplemented with activin A or activin B (50 ng/ml) for 4 days. (A) mRNA
levels of the inhibin a-, bA- and bB-subunits. (B) Follicle diameter was measured in each treatment group after the 4-day culture period. A statistically
significant difference in follicle diameter was noted in the presence of activin A, but not activin B. (C) mRNA levels of the PCSKs in each treatment
group. Bars labeled with different letters indicate statistically significant differences, as determined by Tukey’s multiple comparison test (p,0.05).
*, PSCK7 mRNA transcripts could not be detected by real-time RT-PCR.
doi:10.1371/journal.pone.0017348.g005
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in small follicles when compared to medium and large sized
follicles. Our findings suggest that other proconvertase pathways
are involved in the processing of inhibin in the ovary. Our work
has produced new evidence that PCSK5, and primarily the PC5/
6A isoform, cleaves the inhibin subunits. We demonstrate that the
expression of the inhibin subunits increases in whole ovaries and
mechanically isolated follicles, and that the precursor proteins are
proteolytically activated by PCSK5 (encoding PC5/6 protein) that
is also upregulated during follicle development.
Inhibin A and inhibin B are present in the circulation at very
distinct times during the female reproductive cycle
[32,33,34,35,36], and local activin levels within the ovary also
change during folliculogenesis in a highly regulated manner [35].
As all inhibin subunits are expressed in developing follicles, the
question becomes how processing, assembly and secretion of
mature inhibin and activin dimers are regulated to achieve
cyclical, discordant serum hormone levels. We demonstrate that
the spatial and temporal expression of the proconvertase PCSK5
overlaps with the expression and processing of mature inhibin
subunits in the ovary during follicle development. This suggests
that the proconvertase PC5/6 may be involved in inhibin A
subunit processing in small follicles, as PCSK5 expression
increases during the transition from a 2-layer secondary follicle
(100–130 microns) to a preantral follicle (150–180 microns). While
our work has shown that the inhibin a-subunit is cleaved by furin
(pituitary) and PC5/6 (ovary), it is important to note that cleavage
is not required for inhibin dimerization or secretion. Thus, other
mechanisms, which are likely dependent on the bA- and bB-
subunits, must be in place in order to achieve the discordant levels
of inhibin A and inhibin B during the reproductive cycle.
Activin A is known to be a local regulator of early follicle
development [27,28,29]. We show that activin A, but not activin
B, positively regulates PCSK5 mRNA levels in cultured follicles.
The regulation of proconvertase enzymes by hormones is
supported by a study in prepubertal rats, which demonstrates
gonadotrophin regulation of PCSK5 mRNA [37]. In our proposed
model, local activin A acts in an autocrine/paracrine manner to
stimulate processing of mature inhibin subunits in granulosa cells.
Activin B had no effect on the expression of any of the PCSKs
studied. Endogenous expression of the activin bB-subunit in the
ovary is relatively low compared with the activin bA-subunit;
Figure 6. Expression levels of inhibin subunits and PCSKs in primary cultures of mouse granulosa cells and GRM02 cells. Following
RNA extraction from both cell types, real time PCR analysis was performed using specific primers to the inhibin subunits (A) and the PCSK enzymes
(B). Results are shown in the bar graph and are expressed as a ratio relative to the GAPDH control gene. Data are shown as mean 6 SEM of three
independent experiments. (C) Proconvertase enzymes are necessary for processing of inhibin subunits. GRMO2 cells were cultured for 48 h in the
presence of the proconvertase inhibitor dec-RVRK-CMK (CMK). TCA-precipitated media was separated by SDS-PAGE under reducing conditions and
imunoblotted using an anti-inhibin bA-subunit antibody, (D) anti-inhibin bB-subunit antibody or (E) anti-inhibin a-subunit antibody. The results are
representative of three independent experiments.
doi:10.1371/journal.pone.0017348.g006
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PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e17348Figure 7. Role of PCSKs in inhibin subunit cleavage. (A) Expression of the wild type inhibin a-subunit (RARR) or the a-subunit with modified
cleavage recognition sites (RARA and RAAA) in HEK 293 cells. Culture media were examined by immunoblot analysis under reducing conditions using
an anti-inhibin a-subunit antibody. Processing of the inhibin bB-subunit (B) and inhibin a-subunit (C) by proconvertases. LoVo cells were transiently
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in follicle development by regulating inhibin subunit processing
during the transition from the secondary follicle stage. It is possible
that follicles cultured to the antral stage, when bB-subunit
expression begins to increase, might have demonstrated activin
B-stimulated PCSK5 expression. The effect of inhibins on PCSK5
expression and activity will be investigated in future studies.
It is also interesting that activin A negatively regulates PCSK6
and furin (and possibly PCSK7). This finding confirms the
observations of Diaz et al (2008), who showed suppression of
granulosa cell PCSK6 expression by oocytes [38]. They suggested
that PCSK6 inhibition might represent a mechanism for
regulating the activity of the TGF beta superfamily members
within the developing follicle. There are numerous examples of
paracrine signaling that occur between and among the various
cells that make up the follicle, particularly during early follicle
development [1]. Inhibin subunit processing may be regulated by
an activin feedback loop that occurs between granulosa cells to
ensure that PC5/6 mediates inhibin A processing proceeds
through the preantral stage, followed by processing of inhibin B
in larger follicles. The data suggests that the concurrent increase in
inhibin subunit processing and PSCK5 expression are important
mediators of follicle development. Nonetheless, it is unclear why
activin treatment decreases furin mRNA transcripts in our follicle
culture experiments. Transcriptional regulation studies using a
reporter construct with the furin promoter transiently transfected
into murine granulosa cells and treated with activin is unrespon-
sive. It appears that downregulation of furin mRNA may be
indirect and Smad-independent (data not shown). Whether the
oocyte secretes factors that regulate furin mRNA levels in response
to activin warrants further investigation.
In summary, we have shown that the expression of PCSK5
(encoding PC5/6) correlates with the expression of the inhibin
subunits in the mouse ovary and in individual follicles. Expression
of PCSK5 peaks during the transition from secondary to preantral
follicle stages, and is upregulated by activin A treatment of
cultured mouse follicles. PC5/6 was shown to process the a- and
bB-subunits in cultured cells lines. Future work will continue to
focus on how inhibin subunit processing is coordinated with
subunit expression, dimerization and secretion to achieve the
cyclical patterns of ovarian inhibin and activin production and
activity during the reproductive cycle.
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